Combining 2′-fucosyllactose and galacto-oligosaccharides exerts anti-inflammatory effects and promotes gut health
Open Access
- 1 December 2024
- journal article
- research article
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 107 (12) , 10203-10220
Abstract
This study investigated the potential of 2'-Fucosyllactose (2'-FL) and galactooligosaccharides (GOS) combinations as a novel and cost-effective substitute for human milk oligosaccharides (HMOs) in promoting gut health and reducing inflammation. In vitro studies using Caco-2 cells showed that 2'-FL and GOS combinations (H1: GOS:2'-FL ratio of 1.8:1; H2: ratio of 3.6:1) reduced lipopolysaccharide-induced inflammation by decreasing pro-inflammatory markers, while individual treatments had no significant effects. In a mouse model of dextran sulfate sodium (DSS)-induced colitis, combined 2'-FL and GOS supplementation alleviated symptoms, improved gut permeability, and enhanced intestinal structure, with the GH1 group (H1 combo with DSS) being the most effective. 2'-FL and GOS combinations also enhanced short-chain fatty acid production in infant fecal batch fermentation and mouse fecal analysis, with GH1 showing the most promising results. GH1 supplementation altered gut microbiota in mice with DSS-induced colitis, promoting microbial diversity and a more balanced Firmicutes to Bacteroidota ratio. Infant formula products (IFPs) containing 2'-FL and GOS combinations (IFP2: 174 mg GOS and 95 mg 2'-FL per 14 g serving, 1.8:1 ratio; IFP3: 174 mg GOS and 48 mg 2'-FL per 14 g serving, 3.6:1 ratio) demonstrated gastrointestinal protective and anti-inflammatory properties in a coculture model of Caco-2 and THP-1 cells. These findings suggest that 2'-FL and GOS combinations have potential applications in advanced infant formulas and supplements to promote gut health and reduce inflammation.Keywords
Funding Information
- Korea University
- Korea Institute of Planning and Evaluation for Technology in Food Agriculture Forestry and Fisheries
This publication has 46 references indexed in Scilit:
- Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A reviewBiomedicine & Pharmacotherapy, 2023
- Effect of 2′-fucosyllactose supplementation on intestinal flora in mice with intestinal inflammatory diseasesInternational Dairy Journal, 2020
- Antiviral effects of human milk oligosaccharides: A reviewInternational Dairy Journal, 2020
- Novel strains of Bacteroides fragilis and Bacteroides ovatus alleviate the LPS-induced inflammation in miceApplied Microbiology and Biotechnology, 2019
- Nondigestible oligosaccharides exert nonprebiotic effects on intestinal epithelial cells enhancing the immune response via activation of TLR4‐NFκBMolecular Nutrition & Food Research, 2013
- Bacteroides in the Infant Gut Consume Milk Oligosaccharides via Mucus-Utilization PathwaysCell Host & Microbe, 2011
- The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian ColonCell Metabolism, 2011
- The role and potential of probiotic bacteria in the gut, and the communication between gut microflora and gut/hostInternational Dairy Journal, 2009
- Butyrate modulates oxidative stress in the colonic mucosa of healthy humansClinical Nutrition, 2009
- Marketing Breastfeeding—Reversing Corporate Influence on Infant Feeding PracticesJournal of Urban Health, 2008